Pharvona was born from the personal vision and investment of Dr. Helbert, a dedicated physician who believed in science as a transformative force. He committed his knowledge and capital to a mission: turning scientific possibility into real, accessible treatment. What started as a small research initiative has now grown into an international biotechnology company based in the heart of Europe, specializing in stem cells, exosomes, PRP, and cord tissue banking.